Literature DB >> 6986981

Comparison of the immunosuppressive effects of asparaginases from Escherichia coli and Vibrio succinogenes.

D L Durden, J A Distasio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6986981

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  9 in total

1.  Modulation of lymphocyte proliferation by enzymes that degrade amino acids.

Authors:  J C Chuang; C L Yu; S R Wang
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  The Modified Heparin-Binding L-Asparaginase of Wolinella succinogenes.

Authors:  E P Sannikova; N V Bulushova; S E Cheperegin; I I Gubaydullin; G G Chestukhina; V V Ryabichenko; I A Zalunin; E K Kotlova; G E Konstantinova; T S Kubasova; A A Shtil; V S Pokrovsky; S V Yarotsky; B D Efremov; D G Kozlov
Journal:  Mol Biotechnol       Date:  2016-09       Impact factor: 2.695

3.  Immunological effects of native and polyethylene glycol-modified asparaginases from Vibrio succinogenes and Escherichia coli in normal and tumour-bearing mice.

Authors:  A Bendich; D Kafkewitz; A Abuchowski; F F Davis
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

4.  Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine.

Authors:  Ehsan A Ehsanipour; Xia Sheng; James W Behan; Xingchao Wang; Anna Butturini; Vassilios I Avramis; Steven D Mittelman
Journal:  Cancer Res       Date:  2013-04-12       Impact factor: 12.701

Review 5.  Metabolic reprogramming and metabolic dependency in T cells.

Authors:  Ruoning Wang; Douglas R Green
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

6.  L-asparaginase genes in Escherichia coli: isolation of mutants and characterization of the ansA gene and its protein product.

Authors:  K J Spring; P G Jerlström; D M Burns; I R Beacham
Journal:  J Bacteriol       Date:  1986-04       Impact factor: 3.490

7.  Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase.

Authors:  Wei-Wen Chien; Soraya Allas; Nicolas Rachinel; Pierre Sahakian; Michel Julien; Céline Le Beux; Claire-Emmanuelle Lacroix; Thierry Abribat; Gilles Salles
Journal:  Invest New Drugs       Date:  2014-05-15       Impact factor: 3.850

8.  The differential ability of asparagine and glutamine in promoting the closed/active enzyme conformation rationalizes the Wolinella succinogenes L-asparaginase substrate specificity.

Authors:  Hien Anh Nguyen; Donald L Durden; Arnon Lavie
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

Review 9.  Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy.

Authors:  Maaike Van Trimpont; Evelien Peeters; Yanti De Visser; Amanda M Schalk; Veerle Mondelaers; Barbara De Moerloose; Arnon Lavie; Tim Lammens; Steven Goossens; Pieter Van Vlierberghe
Journal:  Cancers (Basel)       Date:  2022-02-11       Impact factor: 6.639
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.